Being the first natural inhibitor of Ubc13-Uev1A interaction, leucettamol A (93) inhibits the formation of ubiquitin conjugating complex of Ubc13 and Uev1A tumor promoter with IC50 value of 50 μg/mL [115]. Here, UBE2V1 is linked to neoplasm.